Range Nuclear Renaissance ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? Range Nuclear Renaissance ETF trades at $61.06 (market cap $698.21M), while Roivant Sciences Ltd. Common Shares trades at $35.16 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 35.4× Range Nuclear Renaissance ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Range Nuclear Renaissance ETF for 17 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| NUKZ | ROIV | |
|---|---|---|
Market Cap | $698.21M | $24.72B |
Volume | 57,444 | 6,279,442 |
Sector | Sector/Thematic | Health |
52-Week High | $76.23 | $41.81 |
52-Week Low | $60.23 | $16.04 |
Typical Hold Time | 17 Days | 0 Days |
Enterprise Value | — | $20.99B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →